{"url_path":"/sec/cik-0001690384/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 OTHER INFORMATION**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1690384/0001731122-26-000715-index.html","accession_number":"0001731122-26-000715","cik":"0001690384","ticker":null,"issuer_name":"BioCrude Technologies USA, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1690384/0001731122-26-000715-index.html","primary_entity_key":"0001690384","primary_entity_name":"BioCrude Technologies USA, Inc."},"word_count":42,"has_tables":true,"body_markdown":"**ITEM 5. OTHER INFORMATION**\n\n \n\nDuring the quarter ended March 31, 2026, no director\nor officer of the Company adopted or terminated a “Rule 10b-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement”\nas each term is defined in Item 408(a) of Regulation S-K."}